BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20459576)

  • 1. B7-H4 expression in Brenner tumours, a descriptive and comparative study.
    Yee EU; Zaino RJ; Torkko KC; Shroyer KR
    Histopathology; 2010 Apr; 56(5):652-4. PubMed ID: 20459576
    [No Abstract]   [Full Text] [Related]  

  • 2. p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.
    Liao XY; Xue WC; Shen DH; Ngan HY; Siu MK; Cheung AN
    Histopathology; 2007 Oct; 51(4):477-83. PubMed ID: 17880529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer.
    Simon I; Zhuo S; Corral L; Diamandis EP; Sarno MJ; Wolfert RL; Kim NW
    Cancer Res; 2006 Feb; 66(3):1570-5. PubMed ID: 16452214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
    Simon I; Katsaros D; Rigault de la Longrais I; Massobrio M; Scorilas A; Kim NW; Sarno MJ; Wolfert RL; Diamandis EP
    Gynecol Oncol; 2007 Aug; 106(2):334-41. PubMed ID: 17498784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexisting Brenner tumor and struma ovarii in the right ovary: case report and review of the literature.
    Yoshida M; Obayashi C; Tachibana M; Minami R
    Pathol Int; 2004 Oct; 54(10):793-7. PubMed ID: 15482570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic Brenner tumor--a case report.
    Korski K; Breborowicz D; Porzegowski M
    Pol J Pathol; 2005; 56(3):149-51. PubMed ID: 16334984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
    Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
    Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anatomical and clinical deliberations over the Brenner tumor].
    Cernea M; Cordun-Tárábutá G; Gavrilescu C
    Zentralbl Gynakol; 1974 Jun; 96(24):752-9. PubMed ID: 4848036
    [No Abstract]   [Full Text] [Related]  

  • 10. [Brenner tumor. Apropos of 3 recent cases].
    Balouet P; Von Theobald P; Herlicoviez M; Mandard J; Lévy G
    Rev Fr Gynecol Obstet; 1990 Apr; 85(4):263-6. PubMed ID: 2367803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian Brenner tumour with associated stromal sarcoma.
    Noskoviak K; Datnow B
    Histopathology; 2006 Mar; 48(4):467-9. PubMed ID: 16487373
    [No Abstract]   [Full Text] [Related]  

  • 12. Transitional cell tumors of the ovary: a compact group with a heterogeneous histological and immunophenotypical pattern.
    Ceauşu M; Terzea D; Georgescu A; Dobrea C; Mihai M; Iosif C; Vasilescu F; Ardeleanu C
    Rom J Morphol Embryol; 2008; 49(4):513-6. PubMed ID: 19050800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Müllerian mucinous borderline tumors.
    Rutgers JK
    Hum Pathol; 2010 Jan; 41(1):151; author reply 151-2. PubMed ID: 19854468
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinomas of ovary and lung with clear cell features: can immunohistochemistry help in differential diagnosis?
    Howell NR; Zheng W; Cheng L; Tornos C; Kane P; Pearl M; Chalas E; Liang SX
    Int J Gynecol Pathol; 2007 Apr; 26(2):134-40. PubMed ID: 17413979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brenner tumours. Oestrogen activity and coincidence with other neoplasms.
    Punnonen R; Grönroos M; Laurén P
    Acta Obstet Gynecol Scand; 1971; 50(4):363-6. PubMed ID: 5157501
    [No Abstract]   [Full Text] [Related]  

  • 16. [Morphological and histochemical evaluation of benign and malignant forms of Brenner tumors].
    Szymańska K; Miechowiecka N; Czerwiński W
    Ginekol Pol; 1979 Sep; 50(9):761-72. PubMed ID: 510946
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between Heterogeneous Expression of Sialyltransferases and MUC16 in Ovarian Tumor Tissues.
    Bouanene H; Sahrawi W; Mokni M; Fatma LB; Bouriga A; Limen HB; Khairi H; Ahmed SB; Miled A
    Onkologie; 2011; 34(4):165-9. PubMed ID: 21447973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical demonstration of CA 125, CA 19-9 and CEA in normal and pathologically changed adnexa].
    Neunteufel W; Breitenecker G
    Geburtshilfe Frauenheilkd; 1988 May; 48(5):334-7. PubMed ID: 3165079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histogenesis of Brenner tumors, II: histochemistry and CEA.
    Shevchuk MM; Fenoglio CM; Richart RM
    Cancer; 1980 Dec; 46(12):2617-22. PubMed ID: 7004621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report of a malignant Brenner tumor with hyperestrogenism.
    Joh K; Aizawa S; Ohkawa K; Dohzono H; Aida S; Ohgoshi E
    Pathol Int; 1995 Jan; 45(1):75-84. PubMed ID: 7704247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.